Serratus Plane Block and Pectointercostal Block - Trial NCT06381765
Access comprehensive clinical trial information for NCT06381765 through Pure Global AI's free database. This phase not specified trial is sponsored by Cukurova University and is currently Recruiting. The study focuses on Postoperative Pain. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
ultrasound guided Serratus plane bock and pectointercostal block
Interventional
procedure
Sponsor & Location
Cukurova University
Timeline & Enrollment
N/A
May 10, 2024
Aug 10, 2024
Primary Outcome
postoperative morphine consumption,postoperative visual analog scale scores
Summary
ASA I-II female patients aged over 18 who will undergoing breast reduction surgery will
 recruit to the study. Patients will divide into 2 groups. Deep serratus plane block will
 perform with 0,25 %bupivacaine 20 ml at the midaxillary 5. rib, bilaterally for Group I. At
 Group II, deep serratus plane block ( 0,25 %bupivacaine 20 ml) at the midaxillary 5.th rib+
 pectointercostal plane block (0,25% bupivacaine 15 ml) at 4-5.th intercostal space will
 perform bilaterally . General anesthesia with sevoflurane and remifentanil will perform to
 the all patients. Postoperative pain scores, morphine consumption and complications will
 record till the 24.th hours.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06381765
Non-Device Trial